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http:WHAT THIS PAPER ADDS
This is the ﬁrst published cohort study to demonstrate reduced expression of low-density lipoprotein receptor-
related protein 1 (LRP1) in abdominal aortic aneurysm (AAA) compared with normal control aortic tissues from
humans, suggesting that a reduction in LRP1 protein expression may be associated with aneurysm progression.
Our ﬁnding is novel as no study has been reported on the investigation of LRP1 protein expression in AAA and
normal control aortic tissues from humans, although LRP1 gene has been suggested as a lead gene for AAA from
a genome-wide association study.Objective: There are no published data on the expression of low-density lipoprotein receptor-related protein 1
(LRP1) in human aortic tissues with abdominal aortic aneurysm (AAA), although some researchers have
suggested that LRP1 may be a crucial regulator in the pathogenesis of AAA. The aim of this pilot study is to
investigate LRP1 expression in aortic tissues from Chinese patients with AAA compared with normal control
tissues.
Materials and methods: This study used human abdominal aortic tissues with or without AAA as a research
model. Aneurysmal abdominal aortas were collected from Chinese patients with AAA (n ¼ 12) during open
surgical aneurysmal repair at our institution, and normal control non-aneurysmal abdominal aortas were
collected from Chinese healthy organ donors (n ¼ 12) during organ transplantation. Protein expression of LRP1
was analyzed by western blotting and immunohistochemistry.
Results: LRP1 protein expression was signiﬁcantly lower in AAA (mean LRP1AAA/LRP1Normal Control ¼ 0.51  0.28)
than in normal control aortic tissues (mean LRP1Normal Control/LRP1Normal Control ¼ 1  0.18) in our small sample
cohort (p < .001). No signiﬁcant correlation was shown between LRP1 protein expression and the size of AAA
(p > .05).
Conclusions: Our pilot result suggests that a reduction in LRP1 protein expression may be associated with
aneurysm progression.
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ControlsINTRODUCTION
It is now more than 40 years since Clifton reported familial
clustering of abdominal aortic aneurysm (AAA),1 a phe-
nomenon which is well-recognized by most vascular spe-
cialists. Patients who have relatives with AAA are more
likely to be affected themselves.2,3 These observed facts
have therefore led to a search for genetic predisposition
responsible for AAA, to improve understanding of AAArresponding author. Y.C. Chan, Division of Vascular & Endovascular
, Department of Surgery, University of Hong Kong Medical Centre,
Wing, 14th Floor K Block, Queen Mary Hospital, Pokfulam Road,
ong.
il address: ycchan88@hkucc.hku.hk (Y.C. Chan).
-5884/$ e see front matter  2013 European Society for Vascular
. Published by Elsevier Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2013.08.006pathogenesis, and to develop future management
paradigms.4
The inheritance of AAA is likely to be multifactorial.5,6 A
handful of candidate gene association studies for AAA have
been published but results are not always reproducible by
different centres, as studies were underpowered and gave
inconsistent results.7 Some genes are consistently impli-
cated, such as the single nucleotide polymorphisms in genes
of the renin-angiotensin system and of folate metabolism,
which are consistently associated with an increased risk of
developing AAA.8,9 Two common genetic polymorphisms in
transforming growth factor (TGF)-beta receptor were also
found to be associated with AAA, although this association
was mainly driven by ﬁndings in the Netherlands group
and marked between-study heterogeneity was detected
between patients from the Netherlands, New Zealand, and
Western Australia.10 AAA is also associated with
550 C.Y.T. Chan et al.apolipoprotein(a) gene variants rs10455872 and rs3798220,
which correlate with lipoprotein(a) levels and coronary ar-
tery disease.11 Duellman et al. also found signiﬁcant asso-
ciation between matrix metalloproteinase-9 (MMP-9)
genotype and AAA.12 Variation in the ﬁbrillin-1 gene, which
was found to be associated with an increase in arterial pulse
pressure, was suggested to increase the risk of developing
AAA.13 Mutation in type III collagen (COL3A1) was also
suggested to cause AAA.14
One of the genes examined recently in AAA is the low-
density lipoprotein receptor-related protein-1 (LRP1) gene.
The protein encoded by the LRP1 gene is a cell surface
receptor abundantly expressed in liver, lung, brain, intes-
tine, and muscle.15 The LRP1 protein is 600 kDa in size,
comprising a 515 kDa extracellular fragment and a 85 kDa
intracellular and intramembrane fragment.1517 This pro-
tein is classiﬁed as a member of the low-density lipoprotein
receptor (LDLR) family because of the structural
resemblance.1820 LRP1 not only shares structural homol-
ogy with the other LDLR members, but also has the ability
to bind to a diverse group of ligands for regulation of
different cellular processes.15,17 LRP1 is suggested to be
related to AAA as MMP-9, which is abundantly expressed in
AAA tissues for degradation of extracellular matrix proteins,
is reported to bind to LRP1.15,21,22 Also, a knockout study
showed that mice with depletion of LRP1 speciﬁcally in
vascular smooth muscle cells appeared to have aneurysm
formation with dilated aorta.23 More recently, a genome-
wide association study reported that there is a signiﬁcant
association between a variant in the LRP1 gene and AAA,
suggesting that the LRP1 gene may be a lead gene for AAA
formation.24 Although these studies suggested that LRP1
could be a crucial regulator of AAA formation, there is still
no study directly examining LRP1 expression in aortic tissues
from humans. The aim of this paper is to investigate the
LRP1 expression in human aortas from Chinese patients
with AAA, and to compare with normal control tissues.
MATERIALS AND METHODS
Collection of human abdominal aorta specimens
Our centre is a regional tertiary referral centre for vascular
patients and also for patients undergoing organ trans-
plantation. All relevant clinical data including demographics
of patients for research analysis were obtained from the
Hospital Authority’s Clinical Medical System (CMS), which is a
centralized computer database of patient records. All our
subjects were of Chinese ethnicity. Consent for obtaining
human specimen for research was obtained, and this project
was approved by the local institution’s ethics committee.
Full thickness aneurysmal infrarenal aortic samples were
excised at the point of maximum aortic dilatation from 12
patients (mean age  SD ¼ 74.00  8.34; seven males and
ﬁve females) during open surgical aneurysmal repair at our
hospital. These patients were free from connective tissue
disorders, that is Marfan syndrome and Ehlers Danlos syn-
drome. All 12 full thickness AAA specimens were used for
western blotting, but only 10 of the 12 specimens wereused for immunohistochemistry(IHC) as two specimens
were so small in size that they were sufﬁcient only for the
western blotting.
For the normal control group, full thickness infrarenal
abdominal aortas from 12 healthy organ donors (mean
age  SD ¼ 52.92  13.60; ﬁve males and seven females)
without known cardiovascular diseases or connective tissue
disorders were dissected out during organ transplantation.
All 12 normal control full thickness specimens were used for
both western blotting and IHC.
Each of the aortic specimens collected was thoroughly
washed with Dulbecco’s modiﬁed eagle medium (DMEM)
with 10% fetal bovine serum (FBS) (Life Technologies,
Carlsbad, CA, USA) prior to dissection into two parts for
different methods of research analysis, that is western
blotting and IHC.Western blotting
The LRP1 protein expression level in aortic specimens was
analyzed and quantiﬁed by western blotting. Proteins from
100 mg aortic specimens, which was grinded to powder in
liquid nitrogen in advance, were extracted by 1X radio-
immunoprecipitation (RIPA) lysis buffer (Cell Signaling
Technology, Danvers, MA, USA) with 1 mM phenyl-
methanesulfonylﬂuoride (PMSF) (Sigma, St. Louis, MO,
USA). Protein concentration of each aortic tissue sample
was determined using Quick Start Bradford Protein Assay kit
with bovine serum albumin (BSA) as protein standard (Bio-
Rad Laboratories, Hercules, CA, USA). Proteins (20 mg) of
each specimen were resolved by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) (Bio-Rad,
Laboratories) under non-reducing condition as suggested by
the anti-LRP1 antibody [5A6] manual (Abcam, Cambridge,
UK), followed by electroblotting to polyvinylidene diﬂuoride
(PVDF) membrane (GE Healthcare, Little Chalfont, UK) at
4 C overnight. The membrane was probed at 4 C over-
night with mouse monoclonal antibody [5A6] against LRP1
(Abcam) at 1:6000 dilution and rabbit monoclonal antibody
[14C10] against glyceraldehyde 3-phospate dehydrogenase
(GAPDH) (Cell Signaling Technology) at 1:10000 dilution.
Horseradish peroxidase (HRP)-conjugated goat anti-rabbit
or mouse IgG (Invitrogen, Carlsbad, CA, USA) at 1:10000
dilution was used in secondary antibody incubation for 1
hour at room temperature. Band intensity on X-ray ﬁlm
(Fujiﬁlm, Tokyo, Japan) after ECL Prime detection system (GE
Healthcare) was analyzed by Image J software (v1.46, Na-
tional Institutes of Health, Bethesda, MD, USA). The protein
band intensity was measured by cropping the band out for
automatic detection of its brightness. The relative protein
expression level of LRP1 of each specimen was achieved by
the band intensity of LRP1 normalized with the band in-
tensity of GAPDH, which served as a loading control.
Furthermore, the protein expression levels of LRP1 in both
groups, that is AAA and normal control, were normalized
with that of the normal control group, representing the
ratio of LRP1AAA/LRP1Normal Control and LRP1Normal Control/
LRP1Normal Control respectively.
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The LRP1 protein expression in formalin-ﬁxed and parafﬁn-
embedded aortic specimens was analyzed by IHC according
to manufacturer’s protocol (DakoCytomation, Glostrup,
Denmark). The tissue section (6 mm thickness) was incu-
bated at 4 C overnight with mouse monoclonal antibody
[8G1] against LRP1 (Abcam) at a concentration of 10 mg/mL
in antibody diluent (DakoCytomation). Negative control was
performed side by side using the same tissue section under
the same conditions, but with antibody diluent alone during
antibody incubation. HRP-labelled polymer-conjugated goat
anti-mouse antibody (DakoCytomation) was used as sec-
ondary antibody incubation for 1 hour at room tempera-
ture. Liquid 3,30-diaminobenzidine (DAB)þ substrate
chromogen system (DakoCytomation) was applied for
visualization, followed by counterstaining with Mayer’s he-
matoxylin histological staining reagent (DakoCytomation).
The slides were dehydrated and mounted with Permount
mounting medium (Fisher Scientiﬁc, Hampton, NH, USA).
Images of positive staining signal were captured by inverted
microscope (Nikon Eclipses E600) (Nikon, Tokyo, Japan).
Statistics
SPSS 20.0 (IBM Corp., Armonk, NY, USA) was employed in
the statistical analysis.
Both AAA and normal control groups were tested to be
normally distributed (p > .05) by ShapiroeWilk test (p-
value of AAA group ¼ .528; p-value of normal control
group ¼ .355). Independent-samples Student t test was
then used to investigate the statistical differences of LRP1
protein expression between AAA and normal control
groups. The mean LRP1 protein expression level was
expressed as mean  SD.
The investigation on the statistical relationship between
the LRP1 protein expression and the AAA risk factors, that is
age, gender, smoking, hypertension, diabetes, cardiac dis-
ease, pulmonary disease, renal disease, dyslipidemia, and
presence of statin therapy, was done using a linear
regression analysis. Correction for the factors of LRP1
expression was done using a linear model.
The correlation between the size of AAA and LRP1 pro-
tein expression level was analyzed by Pearson correlation
coefﬁcient test.
The level of signiﬁcance was set at .05.
RESULTS
Patient characteristics
There were 12 AAA and 12 normal control aortic specimens
collected from Chinese patients with AAA and healthy organ
donors respectively. The demographic data of AAA patients
and healthy organ donors in this study are listed in Table 1.
Lower LRP1 protein expression in AAA than normal control
aortic tissues
LRP1 protein expression in 12 AAA and 12 normal control
aortic tissues was investigated by western blotting. LRP1proteins were detected in both AAA and normal control
aortic tissues (Fig. 1). However, a reduced expression level
of LRP1 protein was observed in AAA compared with
normal control aortic tissues (Fig. 1A). The normalized LRP1
protein expression level in AAA tissues (n ¼ 12, mean
LRP1AAA/LRP1Normal Control ¼ 0.51  0.28) was decreased by
49% when comparing with that in normal control tissues
(n ¼ 12, mean LRP1Normal Control/LRP1Normal
Control ¼ 1  0.18), showing a signiﬁcant difference
(p < .001) (Fig. 1B).
The observed expression pattern of LRP1 protein in AAA
and normal control aortic tissues was validated by per-
forming IHC on parafﬁn-embedded aortic tissue sections of
10 AAA and 12 normal control specimens. Positive staining
(brown in colour) of LRP1 protein was detected in medial
and adventitial regions of aortas from both AAA and normal
control aortic tissues (Fig. 2). However, relatively less posi-
tive staining of LRP1 protein was observed in AAA (Fig. 2A)
than in normal control aortic tissue sections (Fig. 2B). This
suggests that the AAA tissue sections had a lower LRP1
protein expression than the normal control aortic tissue
sections.
No effect of the risk factors on LRP1 protein expression
No signiﬁcant relationship (p > .05) was found between
LRP1 protein expression and all AAA risk factors, that is age,
gender, smoking, hypertension, diabetes, cardiac disease,
pulmonary disease, renal disease, dyslipidemia, and pres-
ence of statin therapy, by a linear regression analysis
(Table 2). Correction for the factors of LRP1 protein
expression was made by using a linear model. The differ-
ential LRP1 expression between AAA and normal control
groups was robust to correction for the factors in a linear
model (p < .05).
No signiﬁcant correlation between AAA size and LRP1
protein expression
No signiﬁcant correlation was shown between the size of
AAA and LRP1 protein expression (p > .05) (Fig. 3).
DISCUSSION
This is the ﬁrst published cohort study to show a reduced
expression level of LRP1 protein observed in AAA compared
with normal control aortic tissues from humans. The
normalized LRP1 protein expression level in AAA tissues was
about half that of normal control aortic tissues, which was
statistically signiﬁcant. This result suggests that such a
reduction in LRP1 protein expression in human aortic tis-
sues is associated with AAA progression. Our ﬁnding is
novel as no previous study has investigated LRP1 protein
expression in human AAA and normal control aortic tissues
in either Chinese or non-Chinese populations.
Our suggested association of reduced LRP1 expression
with AAA progression may be in the same direction as a
genome-wide association study of a Caucasian popula-
tion.24 Bown et al. showed that there is a signiﬁcant asso-
ciation between a variant in the LRP1 gene and AAA, where
Table 1. Demographic data of AAA and normal control aortic
specimens.
Subgroups AAA
(n ¼ 12)
Normal
control
(n ¼ 12)
Age
(mean
age  SD)
e 74.00  8.34 52.92  13.60
Gender Male 7 (58.33) 5 (41.67)
Female 5 (41.67) 7 (58.33)
Smoking Smoker 1 (8.33) Unknown
Non-smoker 11 (91.67)
Hypertension Disease history 9 (75) 1 (8.33)
Normal 3 (25) 11 (91.67)
Diabetes Disease history 2 (16.67) 0 (0)
Normal 10 (83.33) 12 (100)
Cardiac
diseasea
Disease history 3 (25) 0 (0)
Normal 9 (75) 12 (100)
Pulmonary
diseaseb
Disease history 2 (16.67) 1 (8.33)
Normal 10 (83.33) 11 (91.67)
Renal
diseasec
Disease history 2 (16.67) 0 (0)
Normal 10 (83.33) 12 (100)
Dyslipidemiad Disease history 4 (33.33) 2 (16.67)
Normal 8 (66.67) 10 (83.33)
Statin
therapy
Presence 6 (50) 0 (0)
Absence 6 (50) 12 (100)
The number of patients in the subgroup of each demographic
factor is represented, with percentage shown in brackets.
a Cardiac disease refers to ischaemic heart disease, angina, or
myocardial infarction.
b Pulmonary disease refers to documented lung disease, asthma,
or chronic obstructive pulmonary disease.
c Renal disease refers to renal impairment or end-stage renal
failure.
d Dyslipidemia refers to raised triglycerides or raised cholesterol
levels.
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Figure 1. Analysis of LRP1 protein expression in human abdominal
aortas from 12 patients with abdominal aortic aneurysm (AAA)
and 12 healthy organ donors (normal control) by western blotting.
(A) Representative western blot showing two AAA tissue samples
from two different AAA patients and two normal control tissue
samples from two different healthy organ donors, probing for the
85 kDa-domain of LRP1 and the GAPDH, which was used as a
loading control. Less LRP1 protein expression is observed in AAA
aortas compared with normal control aortas. (B) Scatter plot
showing western blotting result of individual data points of each
group with mean LRP1 expression level  SD. The normalized LRP1
protein expression level of AAA aortas (n ¼ 12,
mean ¼ 0.51  0.28) is signiﬁcantly lower (p < .001) than that of
normal control aortas (n ¼ 12, mean ¼ 1  0.18).
552 C.Y.T. Chan et al.such association is independent of risk factors for general-
ized cardiovascular disease.24 Their study provides an
insight that the lead single nucleotide polymorphism (SNP)
of the LRP1 variant may have a role in AAA formation,
possibly by altering LRP1 expression in aortic tissues.
Our ﬁnding was only that LRP1 protein expression is
reduced in AAA tissues, the exact mechanism of how it is
down-regulated is still unknown. We postulate that such
down-regulation of LRP1 expression may be aided by
microRNA (miR), which is known for gene silencing either by
degradation of mRNA or repression of translation, as one
microRNA, miR-205, is identiﬁed to regulate LRP1.25e27 This
miR-205 is identiﬁed to down-regulate LRP1 expression by
inhibiting translation of LRP1 mRNA into proteins without
affecting its mRNA level, which is in common with our
observation of reduced LRP1 protein expression.27 There-
fore, it is hypothesized that miR-205 is overexpressed in
AAA tissue in suppression of LRP1 translation, resulting in
reduced LRP1 protein expression. Such a hypothesis could
be validated by examining LRP1 mRNA expression in AAA
and normal control aortic tissues by reverse transcription-
polymerase chain reaction (RT-PCR), which is currently in
process. The endogenous miR-205 expression in both aortictissues will also be examined to see if miR-205 is overex-
pressed in AAA tissues.
Our suggested association of reduced LRP1 expression
and AAA progression is in agreement with the knockout
study using a mouse model performed by Boucher et al., as
they found that mice with depletion of vascular smooth
muscle-speciﬁc LRP1 showed aneurysm formation with
dilated aortas.23 Boucher et al. observed aneurysm forma-
tion after depletion of LRP1 in speciﬁcally vascular smooth
muscle cell (VSMCs),23 but it is still uncertain whether the
observation in our study is speciﬁc to the VSMC cell type.
Further validation could be done by performing immuno-
ﬂuorescence double staining on AAA and normal control
tissue sections against LRP1 and VSMC markers, such as
smooth muscle a-actin, in order to identify whether the
reduced LRP1 expression in AAA compared with normal
control tissues is VSMC-speciﬁc.
A very recent mouse model study by Muratoglu et al. also
supports our hypothesis that reduced LRP1 protein
expression may be associated with AAA progression as
Figure 2. Analysis of LRP1 protein expression in parafﬁn-embedded tissue sections of human abdominal aortas from 10 patients with
abdominal aortic aneurysm (AAA) and 12 healthy organ donors (normal control) by IHC. (A) Representative IHC images of different vascular
regions, that is adventitia (AAA1) and media (AAA2), in AAA tissue section probed for 515 kDa-domain of LRP1 protein under 200 (a,e)
and 400 (b,f) magniﬁcations. The corresponding location in the AAA tissue section without LRP1 antibody incubation (negative control)
was imaged under 200 (c,g) and 400 (d,h) magniﬁcations. (B) Representative IHC images of different vascular regions, that is adventitia
(Normal Control 1) and media (Normal Control 2), in normal control tissue section probed for 515 kDa-domain of LRP1 protein under 200
(a,e) and 400 (b,f) magniﬁcations. The corresponding location in the normal control tissue section without LRP1 antibody incubation
(negative control) was imaged under 200 (c,g) and 400 (d,h) magniﬁcations. AAA tissue sections showed relatively less positive staining
(brown) of LRP1 protein than normal control aortic tissue sections.
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nized and degraded elastic lamina.28 The suggested role of
LRP1 in maintaining vascular wall integrity is postulated to
work as posing an antagonistic effect on matrix metal-
loproteinases (MMPs), which are known enzymes for
degradation of extracellular matrix (ECM) proteins in AAA,
as a study using a mouse embryonic ﬁbroblast cell line with
LRP1 depletion showed a reduced ability of binding, inter-
nalization, and degradation of MMP-9.21,2932 It is hy-
pothesized that the reduced LRP1 expression may result in a
lower chance of internalization and degradation of MMP-9
in VSMCs, possibly resulting in a higher chance of ECMprotein degradation and AAA progression. To testify such
hypothesis, LRP1 is suggested to be overexpressed in
VSMCs, followed by analysis of the efﬁciency of MMP-9
internalization and degradation in VSMCs.
The reduced LRP1 expression may be associated with
AAA progression aided by the inﬂammatory process which
is a known factor of AAA pathogenesis, as some studies
reported that the levels of some inﬂammatory cytokines or
mediators, such as tumour necrosis factor-a (TNF-a),
monocyte chemoattractant protein type-1 (MCP-1),
interleukin-6 (IL-6), and activated complement proteases,
were increased in LRP1-deﬁcient mouse models and cell
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Figure 3. The correlation between the size of AAA and LRP1 protein
expression was analyzed by Pearson correlation coefﬁcient test. No
signiﬁcant correlation (p > .05) was shown between AAA size and
LRP1 protein expression (p ¼ .73; Pearson correlation coefﬁcient,
r ¼ .11).
554 C.Y.T. Chan et al.lines.3336 Also, Overtan et al. showed that a higher fre-
quency of fragmentation of elastic lamina occurred in the
LRP1-deﬁcient mice.35 Analysis of the expression of in-
ﬂammatory cytokines or mediators in AAA in comparison
with normal control aortic tissues may help to identify
whether any inﬂammatory response is present.
The proposed role of LRP1 in maintaining vascular wall
integrity may work as posing an agonistic effect on a
cholesterol export protein, ATP-binding cassette trans-
porter A1 (ABCA1), which is identiﬁed for cholesterol
efﬂux from cells and facilitation in high-density lipopro-
tein (HDL)-mediated removal of cholesterol from
body.37,38 It is reported that depletion of LRP1 from
VSMCs in a mouse model resulted in signiﬁcant down-
regulation of ABCA1 expression, leading to reduced
cholesterol efﬂux and an accumulation of excess choles-
terol at the aortic wall.37 The accumulation of cholesterol
at the aortic wall is hypothesized to damage the vascularTable 2. Summary of statistical results showing the relationship
between LRP1 protein expression and the AAA risk factors by
linear regression analysis.
Relationship between
LRP1 protein expression
and AAA risk factors (p)
Age .200
Gender .439
Smoking .820
Hypertension .266
Diabetes .196
Cardiac disease .552
Pulmonary disease .217
Renal disease .171
Dyslipidemia .266
Presence of statin therapy .238
None of the factors, that is age, gender, smoking, hypertension,
diabetes, cardiac disease, pulmonary disease, renal disease,
dyslipidemia, and presence of statin therapy, was signiﬁcantly
related to the LRP1 protein expression (p > .05).wall integrity, possibly increasing the chance of having
AAA. Therefore, further investigation of whether ABCA1
expression is also reduced in AAA compared with normal
control tissues is necessary.
Concerning the maintenance of vascular wall integrity
with the help of cholesterol efﬂux from aortic wall, a pro-
tein known as cholesteryl ester transfer protein (CETP) is
proposed to have anti-atherogenic activity as cholesterol
efﬂux from atherosclerotic lesion is reduced when CETP is
deﬁcient.39 Although such anti-atherogenic activity of CETP
is postulated to help protect the aortic wall integrity and
hence possibly result in a lower chance of AAA develop-
ment, there is still no study reported on the involvement of
CETP in AAA prevention, nor the relationship between CETP
and LRP1. Therefore, investigation of endogenous CETP
expression in AAA compared with normal control tissues is
necessary. The question of whether CETP works coopera-
tively with LRP1 in prevention of AAA remains to be
investigated.
A previous study reported that hepatic LRP1 expression
was increased after endogenous hydroxymethylglutaryl-
coenzyme A (HMG co-A) reductase was inhibited by ator-
vastatin using in vitro and in vivo methods.40 However,
there is still no study investigating whether HMG co-A
reductase inhibitor, statin, increases LRP1 expression in
VSMCs of the aorta. As no signiﬁcant relationship was
shown between LRP1 expression in the aorta and statin in
our study, further investigation with a larger sampling size is
necessary.
This current study has some limitations. The major limi-
tation is the relatively small sampling size. Because there is
a growing trend for using endovascular aneurysm repair
(EVAR) for aneurysmal repair rather than open surgery,
where the AAA aortic samples are excised from patients, a
limited amount of AAA samples were collected for study.
Therefore, a further large-scale study recruiting more Chi-
nese patients with AAA from different geographic areas of
China would ascertain the current ﬁnding. Also, as our study
is small-scale, the inﬂuence of the confounding risk factors,
such as age, gender, smoking, hypertension, diabetes, car-
diac disease, pulmonary disease, renal disease, dyslipide-
mia, and presence of statin therapy, may be small and
hence our pilot study showed no signiﬁcant effect of those
risk factors on LRP1 expression. With the recruitment of
more patients for a larger-scale study, the effect of the risk
factors on LRP1 expression could be further validated. Also,
our study did not show any signiﬁcant correlation between
the size of AAA and LRP1 protein expression, proposing that
the size of AAA may not be a determining factor of LRP1
expression. A large-scale study could help validate whether
LRP1 expression is independent of the size of AAA. Sub-
group analysis of those with or without cardiovascular dis-
eases may further support our ﬁnding that LRP1 modulation
is speciﬁc to AAA formation. The experimental limitation of
this study is the possibility of band saturation of western
blot, although the condition was optimized by diluting the
antibodies and reducing the exposure time. Further repeats
in the future large-scale study incorporating the use of
European Journal of Vascular and Endovascular Surgery Volume 46 Issue 5 p. 549e556 November/2013 555another LRP1 antibody and loading marker, such as b-actin,
is necessary.
In summary, LRP1 protein expression was found to be
signiﬁcantly reduced in AAA when comparing with normal
control aortic tissues in our small cohort from a Chinese
population. No signiﬁcant correlation was shown between
the size of AAA and LRP1 expression. This pilot study sug-
gests that the reduced LRP1 protein expression may be
associated with AAA progression. A further large-scale study
recruiting more Chinese patients with AAA should be con-
ducted to ascertain this ﬁnding.
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